CA
NZ
UK
AU
IND
US
M-tron Industries, Inc. filed a Form 8-K on August 31, 2026, disclosing under Regulation FD that the company made available a slide presentation accompanying its appearance at the 17th Annual Midwest IDEAS Conference on August 27, 2026.
News Corporation filed a current report on Form 8-K on August 31, 2026, disclosing information provided to the Australian Securities Exchange regarding the company's ongoing stock repurchase program, with the earliest reported event dated August 28, 2026.
Albany International Corp. filed a Form 8-K with the SEC on August 31, 2026, disclosing that Chief Financial Officer Willard Station has commenced a medical leave of absence and that Sean Valashinas has been appointed acting principal financial officer effective the same date.
A Form 4 filed on August 28, 2026, with the U.S. Securities and Exchange Commission reports that Robert David Thomas, a Senior Vice President of International Business Machines Corp, sold 25,000 shares of IBM common stock on August 26, 2026.
A Form 4 filed with the SEC on August 28, 2026 reports that Arvind Krishna, Chairman, President and CEO of International Business Machines Corp (NYSE:IBM), acquired 8,375.5601 phantom stock units under the IBM Excess Savings Plan on August 27, 2026.
Joshua Aiello, Principal Accounting Officer of Orchestra BioMed Holdings, Inc., filed a Statement of Changes in Beneficial Ownership on August 28, 2026, reporting a disposition of common shares on August 26, 2026 in connection with restricted stock unit vesting.
Director Kimberly Park filed a Form 4 with the SEC on August 28, 2026, reporting the exercise and sale of stock options in Corcept Therapeutics Incorporated (NASDAQ:CORT) on August 26, 2026.
Andrew Lawrence Taylor, Chief Financial Officer of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO), filed a Form 4 on August 28, 2026, disclosing a share withholding transaction dated August 26, 2026, in connection with the vesting of restricted stock units.
Darren Sherman, President and Chief Operating Officer of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO), filed a Form 4 on August 28, 2026, disclosing two transactions in Common Stock dated August 26, 2026.
Manjunath Gangadharan, VP and Chief Accounting Officer of Covista Inc. (NASDAQ:CVSA), filed a Form 4 on August 28, 2026, disclosing the sale of 1,802 shares of common stock on August 27, 2026.
Please wait processing your request...